Please provide your email address to receive an email when new articles are posted on . The first-in-human trial assessed the safety and efficacy of the PRIMA photovoltaic retinal stimulation ...
SEATTLE--(BUSINESS WIRE)--LumiThera Inc., a medical device company offering photobiomodulation (PBM) treatment for ocular damage and disease, today announced the U.S. Food & Drug Administration (FDA) ...
SEOUL, South Korea, Nov. 11, 2025 /PRNewswire/ -- STRADVISION, a global leader in AI-based vision perception technology, today announced a multi-year collaboration with AMD to redefine the future of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback